Terms: = Prostate cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Diagnosis
24 results:
1. Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer.
Hung A; Candelieri D; Li Y; Alba P; Robison B; Agiri F; Perez C; Lee KM; Maxwell KN; Li W; Aggarwal H; Pridgen K; Reed SD; DuVall S; Wong YN; Lynch JA
Semin Oncol; 2023; 50(1-2):11-24. PubMed ID: 37055240
[TBL] [Abstract] [Full Text] [Related]
2. Racial Analysis of Clinical and Biochemical Outcomes in Patients With prostate cancer Treated With Low-Dose-Rate Brachytherapy.
Kerans SJ; Samanta S; Vyfhuis MAL; Guerrero M; Bang CK; Mishra MV; Rana Z; Amin PP; Kwok Y; Naslund MJ; Molitoris JK
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):87-95. PubMed ID: 36336224
[TBL] [Abstract] [Full Text] [Related]
3. Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms.
Lucciola S; Pisciotti ML; Frisenda M; Magliocca F; Gentilucci A; Del Giudice F; Canale V; Scarrone E; Busetto GM; Carrieri G; Cormio L; Carbone A; Pastore A; De Nunzio C; Tubaro A; Leonardo C; Franco G; Di Pierro GB; Salciccia S; Sciarra A; Panebianco V
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):379-387. PubMed ID: 35732820
[TBL] [Abstract] [Full Text] [Related]
4. prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives.
Zheng G; Sundquist J; Sundquist K; Ji J
Cancer Med; 2022 May; 11(10):2117-2124. PubMed ID: 35312170
[TBL] [Abstract] [Full Text] [Related]
5. Integration of quantitative diffusion kurtosis imaging and prostate specific antigen in differential diagnostic of prostate cancer.
Yao W; Zheng J; Han C; Lu P; Mao L; Liu J; Wang G; Zou S; Li L; Xu Y
Medicine (Baltimore); 2021 Sep; 100(35):e27144. PubMed ID: 34477170
[TBL] [Abstract] [Full Text] [Related]
6. Distinct Metabolic Signatures of Hormone-Sensitive and Castration-Resistant prostate cancer Revealed by a
Zheng H; Zhu Y; Shao X; Cai A; Dong B; Xue W; Gao H
J Proteome Res; 2020 Sep; 19(9):3741-3749. PubMed ID: 32702989
[TBL] [Abstract] [Full Text] [Related]
7. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
Lancet Oncol; 2020 Feb; 21(2):222-232. PubMed ID: 31926806
[TBL] [Abstract] [Full Text] [Related]
8. [Resilience in Long-Term cancer Survivors - Associations with Psychological Distress and Sociodemographic Characteristics].
Plitzko L; Mehnert-Theuerkauf A; Götze H
Psychother Psychosom Med Psychol; 2020 May; 70(5):182-189. PubMed ID: 31315142
[TBL] [Abstract] [Full Text] [Related]
9. RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for prostate cancer.
Hou Q; Bing ZT; Hu C; Li MY; Yang KH; Mo Z; Xie XW; Liao JL; Lu Y; Horie S; Lou MW
EBioMedicine; 2018 Jun; 32():234-244. PubMed ID: 29861410
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence and initial prescription of psychotropics in patients with common cancers in Japan, based on a nationwide health insurance claims database.
Sato I; Onishi H; Yamada S; Kawakami K
Psychooncology; 2018 Feb; 27(2):450-457. PubMed ID: 28750146
[TBL] [Abstract] [Full Text] [Related]
11. The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.
Nygård LH; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
Prostate; 2017 Jun; 77(9):1029-1035. PubMed ID: 28480542
[TBL] [Abstract] [Full Text] [Related]
12. Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer.
Wang J; Wu CJ; Bao ML; Zhang J; Wang XN; Zhang YD
Eur Radiol; 2017 Oct; 27(10):4082-4090. PubMed ID: 28374077
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
[TBL] [Abstract] [Full Text] [Related]
14. Evolution of the patient characteristics of candidates for radical prostatectomy and the results obtained with the technique.
Sanchís-Bonet A; Arribas-Gómez I; Sánchez-Rodríguez C; Sánchez-Chapado M
Actas Urol Esp; 2015 Mar; 39(2):78-84. PubMed ID: 24909335
[TBL] [Abstract] [Full Text] [Related]
15. The percentage of core involved by cancer is the best predictor of insignificant prostate cancer, according to an updated definition (tumor volume up to 2.5 cm3): analysis of a cohort of 210 consecutive patients with low-risk disease.
Antonelli A; Vismara Fugini A; Tardanico R; Giovanessi L; Zambolin T; Simeone C
Urology; 2014 Jan; 83(1):28-32. PubMed ID: 24269219
[TBL] [Abstract] [Full Text] [Related]
16. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.
Nepple KG; Stephenson AJ; Kallogjeri D; Michalski J; Grubb RL; Strope SA; Haslag-Minoff J; Piccirillo JF; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Kibel AS
Eur Urol; 2013 Sep; 64(3):372-8. PubMed ID: 23506834
[TBL] [Abstract] [Full Text] [Related]
17. Racial variation in the quality of surgical care for prostate cancer.
Barocas DA; Gray DT; Fowke JH; Mercaldo ND; Blume JD; Chang SS; Cookson MS; Smith JA; Penson DF
J Urol; 2012 Oct; 188(4):1279-85. PubMed ID: 22902011
[TBL] [Abstract] [Full Text] [Related]
18. The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study.
Haillot O; Fraga A; Maciukiewicz P; Pushkar D; Tammela T; Höfner K; Chantada V; Gagnier P; Morrill B
Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):302-6. PubMed ID: 21502969
[TBL] [Abstract] [Full Text] [Related]
19. Participation of older patients with prostate cancer in Medicare eligible trials.
Craig BM; Gilbert SM; Herndon JB; Vogel B; Quinn GP
J Urol; 2010 Sep; 184(3):901-6. PubMed ID: 20643449
[TBL] [Abstract] [Full Text] [Related]
20. Symptoms, care needs and diagnosis in palliative cancer patients in acute care hospitals: a 5-year follow-up survey.
Sandgren A; Fridlund B; Nyberg P; Strang P; Petersson K; Thulesius H
Acta Oncol; 2010 May; 49(4):460-6. PubMed ID: 20121671
[TBL] [Abstract] [Full Text] [Related]
[Next]
